source · text/csv
source_e4eb8c5145634f6d
sha256 12eb0591485452fe3b0d6b2aa80fe6591af3a1b7521acbc959a5003c73bdd6c6
by researka:v2 · 2026-06-09 01:11:58.568216+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Comparative Effectiveness of CagriSegma , Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide promotes bone marrow–derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER ),not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Once-Weekly Semaglutide in Adults With Daily Cigarette Use,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trials",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Studenski 2011,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Perera 2006,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation ADA 2024,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation WHO 2000,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Cruz-Jentoft 2019,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Anisimov 2008,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Tancredi 2015,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Schulz 2010,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Ioannidis 2005,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "3d14b1df-ee4d-403d-8542-096906fcf3f0",
"researka_submission_id": "b959d526-e557-413c-bf7f-d60cb2c53fa6",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/3d14b1df-ee4d-403d-8542-096906fcf3f0/sidecars/evidence_table.csv"
}